Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.HemCon Medical Technologies has entered into an agreement with ENTrigue Surgical, for the development and distribution of its Synaero Hemostatic Gel.
Subscribe to our email newsletter
Based on HemCon’s proprietary oxidised cellulose platform, Synaero Hemostatic Gel is a hemostatic gel to be used during and after ENT surgical procedures to control bleeding, minimise edema and prevent adhesions.
HemCon claims that Synaero Hemostatic Gel is designed to be easily administered endoscopically to the nasal cavity and lightly coat the mucosal tissue to control bleeding.
HemCon president and CEO John Morgan said that Synaero is the perfect complement to ENTrigue’s line of otolaryngology products and they are a strong partner in the industry having gained the trust of clinicians with their expertise.